Home | Back to newsletter main page
| If you have trouble viewing this page, click here to view the newsletter online on our website. | |
 |
|
July 25, 2011 |
|
CASE CCC IN THE NEWSPilot Study on Pancreatic Cancer Detection Begins Enrollment Largest Ob/Gyn Group Backs Annual Mammograms in 40s Cleveland Clinic Trials Could Yield Advances in Kidney-Cancer Treatment ANNOUNCEMENTSHHS Announces Proposal to Improve Rules Protecting Human Research SubjectsThe US Department of Health and Human Services announced today that the federal government is contemplating various ways of enhancing the regulations overseeing research on human subjects. Before making changes to the regulations – which have been in place since 1991 and are often referred to as the Common Rule – the government is seeking the public's input on an array of issues related to the ethics, safety, and oversight of human research. ACS Pan Ohio Hope RideAt 7:30 am this Thursday, July 28, the Pan Ohio Hope Riders will be riding through University Circle to begin their bicycle ride to Columbus; many of the riders will continue to Cincinnati. We encourage you to cheer the riders on as they pass through the area. We wish the best of luck to all participants, especially the following Cancer Center members: Clinical Research Scholar Career Development Training OpportunityThe CTSC KL2 seeks outstanding candidates to fill Clinical Research (CR) Scholar positions available in July 2012. The training program is funded by the NIH and it is a component of the Cleveland Clinical and Translational Science Collaborative. This innovative program is a collaboration involving CWRU, Cleveland Clinic, UH and MetroHealth. Each CR Scholar will embark on a 4-year program of intensive training in interdisciplinary team-based, patient-oriented research, combining a novel educational program with mentored research experiences. Interested applicants are encouraged to attend upcoming informational sessions. To make a reservation, please contact contact Beth Spyke, MPA at spykeb@ccf.org or 216-444-2702. Applications will be accepted through October 10. MARK YOUR CALENDARSMinority Recruitment and Cancer Research RetreatMark your calendars for the Minority Recruitment and Cancer Research Retreat, August 30 from 3-6 pm in the Wolstein Research Building Auditorium. Please join us as we explore in a retreat setting (plenary and break-out sessions) issues related to minority recruitment to cancer clinical trials. Registration will be required due to a limited space. Stay tuned! Imaging Solutions In Cancer Management: A Case-Based ConferenceRegistration is now open for Imaging Solutions In Cancer Management: A Case-Based Conference. Join us September 8 for this comprehensive oncologic imaging course, which focuses on cancer management using imaging as a diagnostic tool and as a guide for minimally invasive therapeutic applications. This course takes a practical approach using cases and features multiple specialists ranging from medical oncologists, radiation oncologists, surgeons, radiologists and basic scientists. |
EVENTS
**All events are open to anyone interested in attending July 25Hematology Oncology Seminar July 26July 27Hematology and Oncology Research Conference July 28Immunology Invited Speaker Seminar Series July 29Cancer Center Research in Progress Seminar will resume September 2. Hematology/Oncology Fellows Curriculum Series
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTSOlof Pearson Lecture Imaging Solutions in Cancer Management: A Case-based Conference ADDITIONAL UPCOMING SEMINARS & EVENTSMSC 2011: Innovations in Cell-Based Regenerative Therapies First Ascoli Piceno Conference on Gene Vaccination in Cancer 8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions |
FUNDING OPPORTUNITIESProstate Cancer Foundation Young Investigator AwardsThe Prostate Cancer Foundation is accepting applications for their Young Investigator Awards. Highly innovative basic science programs will be carefully considered, but priority will be given to "bench to bedside" translational research proposals with the potential to deliver near term benefit to patients. Deadline: August 1 Vilcek Prize for Creative Promise in Biomedical ScienceThe Vilcek Foundation is accepting applications for the Vilcek Prize for Creative Promise in Biomedical Science. This prize will be awarded to a young foreign-born scientist who demonstrates outstanding early achievement in the field of biomedical science. Eligible work can be in basic, applied or translational biomedical science. Deadline: August 14 Susan G. Komen for the Cure Post Baccalaureate Training in Disparities ResearchSusan G. Komen for the Cure is accepting applications for Post Baccalaureate Training in Disparities Research (PBT-DR) grants, which are intended to establish or sustain a training program headed by a mentor(s) to provide pre-masters or pre-doctoral students with the analytic, research, scientific, clinical and/or public health skills. These skills are critical to effectively explore the basis for differences in breast cancer outcomes and translate research discoveries into clinical and public health practice. PBT-DR grants have the ultimate goal to eliminate disparities in breast cancer outcomes across population groups. Pre-Application Deadline: August 30 Concern Foundation CONquer canCER Now AwardThe Concern Foundation is now accepting applications for the CONquer canCER Now award. Grants will only be awarded to independent investigators at the level of Assistant Professor (or equivalent with explanation). The Concern Foundation will require a letter from the applicant's department chair attesting to the applicant's faculty status and to the applicant's status as an independent investigator with independent laboratory space. This will need to be submitted along with the initial Letter of Intent from prospective applicants. LOI Deadline: September 8 National Lung Cancer Partnership Young Investigator Research GrantApplications are being accepted for National Lung Cancer Partnership Young Investigator Research Grants. The purpose of these awards is to drive forward research that will increase understanding of lung cancer risk, biology, and response to treatment. At the time of application, an applicant must hold a doctoral degree (MD, PhD, DO, DrPH, or equivalent) and be a post-doctoral fellow or within the first 5 years of faculty appointment at a not-for-profit institution in the United States or Canada. Deadline: September 9 Lustgarten Foundation Innovator Awards Program- Basic ResearchThe Lustgarten Foundation is pleased to announce its 2011 Innovator Awards Program to fund novel, "out of the box" concepts in basic research. Interested applicants should submit a Concept Proposal. These will be reviewed and the Foundation will contact Principal Investigators of selected Concepts to invite the submission of full proposals. Concept Deadline: September 12 Leukemia & Lymphoma Society (LLS) Career Development Program (CDP)The Leukemia & Lymphoma Society (LLS) Career Development Program (CDP) is accepting applications for career development awards for various stages of research careers: Scholar: Open to highly qualified investigators who have shown a capacity for independent, sustained original investigation in the field of leukemia, lymphoma and myeloma. Applicant must hold an independent faculty-level or equivalent position and have obtained substantial support for research from a national agency. Letter of Intent Deadline: September 15 Scholar in Clinical Research: Applicants must be highly qualified investigators who hold an independent faculty-level appointment and are conducting original, independent applied research, often involving early-stage clinical trials that will advance the prevention, diagnosis or treatment of hematologic malignancies. Applicant is expected to have concomitant support for research from another source or agency. Letter of Intent Deadline: September 15 Special Fellow: Applicants must be qualified investigators who have completed a minimum of two years of postdoctoral research training and are continuing to conduct research under the research sponsor's direction. This award is meant to permit applicants to begin to transition to an independent research program. Letter of Intent Deadline: September 15 Special Fellow in Clinical Research (SFCR): Open to researchers who hold a PhD, MD, or equivalent degree and have completed at least two years of clinical hematology, oncology, hematology/oncology or hematopathology training or postdoctoral research training in a clinical discipline (such as cytogenetics or molecular pathology). Applicants must show evidence that their career focus will be on preventing, diagnosing or treating leukemia, lymphoma or myeloma. Letter of Intent Deadline: September 15 Fellow: Open to promising investigators with less than two years of postdoctoral research training. This award encourages researchers to embark on an academic career involving clinical or fundamental research in, or related to, leukemia, lymphoma or myeloma under a research sponsor's direction. Letter of Intent Deadline: September 15 Fiscal Year 2012 Defense University Research Instrumentation Program (DURIP)The DOD announces the Fiscal Year 2012 Defense University Research Instrumentation Program (DURIP), a part of the University Research Initiative (URI). DURIP is designed to improve the capabilities of US institutions of higher education to conduct research and to educate scientists and engineers in areas important to national defense, by providing funds for the acquisition of research equipment. This announcement seeks proposals to purchase instrumentation in support of research in areas of interest to the DOD, including areas of research supported by the administering agencies. Deadline: September 20 Szent-Györgyi Prize for Progress in Cancer ResearchSzent-Györgyi Prize for Progress in Cancer Research was established to honor an outstanding researcher whose scientific achievements have expanded our understanding of cancer and cancer causation; whose vision has moved cancer research in new directions; and whose discoveries have resulted in notable advances in cancer prevention, diagnosis, or treatment. The Prize also promotes public awareness of the importance of basic cancer research and encourages the sustained investment needed to accelerate the translation of these research discoveries into new cancer treatments. Nominations for the Prize may be made by individuals from the research community, industry, government, or other organizations who are sufficiently familiar with the research accomplishments and contributions of the nominee. Self-nominations will not be accepted. Nomination Deadline: September 30 Robert Wood Johnson Foundation Scholars in Health Policy Research programThe Robert Wood Johnson Foundation Scholars in Health Policy Research program develops and supports a new generation of creative health policy thinkers and researchers within the disciplines of economics, political science and sociology. Each year the program selects up to nine highly qualified individuals for two-year fellowships at one of three nationally prominent universities with the expectation that they will make important research contributions to future US health policy. Deadline: October 12 The Leukemia & Lymphoma Society Specialized Center of Research ProgramThe Marshall A. Lichtman Specialized Center of Research (SCOR) program is the Leukemia & Lymphoma Society's most ambitious research opportunity to date. This innovative program supports interdisciplinary research across at least three independent research projects that are integrated and supported by scientific core laboratories. Members of our SCOR teams include some of the brightest medical specialists in the field of leukemia, lymphoma and myeloma research, brought together to be part of a highly organized and inspired team approach to speed the discovery of new drugs and curative treatment. Deadline: November 1 Case CCC Clinical Trials Funding OpportunityThe Case Comprehensive Cancer Center is announcing the availability of Protocol Specific Research Support (PSRS) funding for Year 2011. The budgeted funds are for the conduct of early phase clinical trial and restricted to support research nurses and data managers directly involved in the conduct of these clinical trials. Studies developed jointly between UH and CCF with planned accrual at both institutions will be prioritized. Please direct questions and requests for information about the funding process to Katarzyna Karelus, Administrative Director, Case Comprehensive Cancer Center Clinical Research Office, at (216) 368-6287 or kxk384@case.edu. |
|
PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES |
|
|
2012 Searle Scholar Program |
Induced Pluripotent Stem Cell Pilot Research Award |
|
|
|
NIH BULLETIN – Notices and Funding OpportunitiesSleep and Social Environment: Basic Biopsychosocial Processes (R21) (RFA-HD-12-204) Building Interdisciplinary Research Careers in Womens Health (K12)(RFA-OD-11-002) Research Project Grant (Parent R01) (PA-11-260) NIH Exploratory/Developmental Research Grant Program (Parent R21) (PA-11-261) |
|
| Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216-844-8317 phone 216-844-7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
|
|